Compare Guardant Health Inc. Common Stock (GH) vs Okta, Inc. (OKTA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Guardant Health Inc. Common Stock vs Okta, Inc. — how do they compare? Guardant Health Inc. Common Stock trades at $165.58 (market cap $22.58B), while Okta, Inc. trades at $221.54 (market cap $38.11B). The key difference: Okta, Inc. is the larger of the two by market cap, and Okta, Inc. is trading nearer its 52-week high, Guardant Health Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 0 Days and Okta, Inc. for 44 Days on average.
| GH | OKTA | |
|---|---|---|
Market Cap | $22.58B | $38.11B |
Volume | 2,200,599 | 2,259,293 |
Sector | Health | Technology |
52-Week High | $187.22 | $220.21 |
52-Week Low | $61.73 | $62.93 |
Typical Hold Time | 0 Days | 44 Days |
Enterprise Value | $23.22B | $35.86B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
OKTA trades at $220.21, up 0.7% with strong technical momentum and bullish moving averages. The company shows improving fundamentals with revenue growth from $2.3B to $2.6B and a return to profitability in 2025. Recent earnings beats and positive analyst sentiment (73.6% buy ratings) support the bullish case, though high valuation multiples and insider selling present cautionary notes.
Outlook remains positive with AI security initiatives driving growth potential, but investors face valuation risks at current levels. The stock trades above consensus price target, suggesting limited near-term upside despite strong operational improvements and market positioning in the cybersecurity sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Guardant Health Inc. Common Stock
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →About Okta, Inc.
Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.
Read more on OKTA →
